Cytokinetics Inc (CYTK)
60.20
+0.84
(+1.42%)
USD |
NASDAQ |
May 15, 14:59
Cytokinetics Accounts Payable (Quarterly): 12.97M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.97M |
December 31, 2023 | 21.51M |
September 30, 2023 | 13.80M |
June 30, 2023 | 12.56M |
March 31, 2023 | 17.36M |
December 31, 2022 | 25.61M |
September 30, 2022 | 14.43M |
June 30, 2022 | 14.08M |
March 31, 2022 | 19.84M |
December 31, 2021 | 21.09M |
September 30, 2021 | 16.22M |
June 30, 2021 | 14.93M |
March 31, 2021 | 7.766M |
December 31, 2020 | 8.05M |
September 30, 2020 | 6.738M |
June 30, 2020 | 2.92M |
March 31, 2020 | 3.527M |
December 31, 2019 | 8.16M |
September 30, 2019 | 3.412M |
June 30, 2019 | 5.194M |
March 31, 2019 | 2.547M |
December 31, 2018 | 3.764M |
September 30, 2018 | 2.024M |
June 30, 2018 | 1.336M |
March 31, 2018 | 2.424M |
Date | Value |
---|---|
December 31, 2017 | 5.253M |
September 30, 2017 | 4.079M |
June 30, 2017 | 1.783M |
March 31, 2017 | 3.042M |
December 31, 2016 | 4.236M |
September 30, 2016 | 0.668M |
June 30, 2016 | 2.846M |
March 31, 2016 | 0.547M |
December 31, 2015 | 2.238M |
September 30, 2015 | 1.907M |
June 30, 2015 | 1.601M |
March 31, 2015 | 1.392M |
December 31, 2014 | 1.361M |
September 30, 2014 | 1.646M |
June 30, 2014 | 0.985M |
March 31, 2014 | 1.689M |
December 31, 2013 | 3.709M |
September 30, 2013 | 1.789M |
June 30, 2013 | 1.801M |
March 31, 2013 | 1.086M |
December 31, 2012 | 2.152M |
September 30, 2012 | 1.518M |
June 30, 2012 | 1.046M |
March 31, 2012 | 0.926M |
December 31, 2011 | 1.208M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.92M
Minimum
Jun 2020
25.61M
Maximum
Dec 2022
12.51M
Average
13.38M
Median
Accounts Payable (Quarterly) Benchmarks
Amgen Inc | 1.628B |
Johnson & Johnson | 8.174B |
Eli Lilly and Co | 2.474B |
Viking Therapeutics Inc | 5.225M |
Madrigal Pharmaceuticals Inc | 21.53M |